Cargando…
Complete twelve month bone remodeling with a bi-phasic injectable bone substitute in benign bone tumors: a prospective pilot study
BACKGROUND: Benign primary bone tumors are commonly treated by surgery involving bone grafts or synthetic bone void fillers. Although synthetic bone grafts may provide early mechanical support while minimizing the risk of donor-site morbidity and disease transmission, difficult handling properties a...
Autores principales: | Kaczmarczyk, Jacek, Sowinski, Piotr, Goch, Maciej, Katulska, Katarzyna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4661983/ https://www.ncbi.nlm.nih.gov/pubmed/26612576 http://dx.doi.org/10.1186/s12891-015-0828-3 |
Ejemplares similares
-
Preliminary Results of Highly Injectable Bi-Phasic Bone Substitute (CERAMENT) in the Treatment of Benign Bone Tumors and Tumor-like Lesions
por: Kotrych, Daniel, et al.
Publicado: (2018) -
Treatment of benign bone lesions with an injectable biphasic bone substitute
por: Döring, Kevin, et al.
Publicado: (2022) -
Fabrication of 3D Bioprinted Bi-Phasic Scaffold for Bone–Cartilage Interface Regeneration
por: Chen, Hongyi, et al.
Publicado: (2023) -
Sr and Mg Doped Bi-Phasic Calcium Phosphate Macroporous Bone Graft Substitutes Fabricated by Robocasting: A Structural and Cytocompatibility Assessment
por: Besleaga, Cristina, et al.
Publicado: (2022) -
Hydroxyapatite crystals as a bone graft substitute in benign lytic lesions of bone
por: Gupta, Anil Kumar, et al.
Publicado: (2015)